Catherine Cohet

European Medicines Agency — Netherlands

Social Sciences · Social Sciences

24h-index1.8kcitations68works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Vaccine Coverage and Hesitancy(14), SARS-CoV-2 and COVID-19 Research(12), Cervical Cancer and HPV Research(11), Influenza Virus Research Studies(11), Viral gastroenteritis research and epidemiology(8)

Publications68 total

Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance ( <scp>ENCePP</scp> )
Pharmacoepidemiology and Drug Safety·2025Open Access
An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union
European Journal of Public Health·2025Open Access
ENCePP Special Series. Strengthening pharmacoepidemiology in a changing research environment: the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
2025Open Access
Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study
The Lancet Digital Health·2025· 2 citedOpen Access
Collaborative Real‐World Evidence Among Regulators: Lessons and Perspectives
Clinical Pharmacology & Therapeutics·2024· 4 citedOpen Access
Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China
Human Vaccines & Immunotherapeutics·2024· 1 citedOpen Access
An extension of the Benefit Risk Assessment of VaccinEs (BRAVE) Toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union
2024Open Access
Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes
Nature Communications·2024· 17 citedOpen Access
Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry
Pharmacoepidemiology and Drug Safety·2024Open Access
Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States
Clinical Epidemiology·2024· 7 citedOpen Access
MOnitoring human papillomavirus Vaccine effect on Infection and cErvical diseases (MOVIE): Protocol for a cohort study using electronic health records from Yinzhou, China
Human Vaccines & Immunotherapeutics·2023· 5 citedOpen Access
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses
BMJ·2023· 25 citedOpen Access
HLA Alleles, COVID-19 Vaccine Antibody Response and Real-World Breakthrough Outcomes
Research Square (Research Square)·2023· 1 citedOpen Access
A feasibility assessment of real‐world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case
Pharmacoepidemiology and Drug Safety·2023· 7 citedOpen Access
Assessing heterogeneity of electronic health‐care databases: A case study of background incidence rates of venous thromboembolism
Pharmacoepidemiology and Drug Safety·2023· 11 citedOpen Access
Regulation of Vaccines in Europe
Elsevier eBooks·2023
A Digital Tool to Contextualise the Benefit Risk of COVID-19 Vaccines in the European Union: The Benefit Risk Assessment of Vaccines (BRAVE) Toolkit
SSRN Electronic Journal·2023· 1 citedOpen Access
Contributors
Elsevier eBooks·2023
Safety Monitoring of <scp>COVID</scp>‐19 Vaccines: Perspective from the European Medicines Agency
Clinical Pharmacology & Therapeutics·2022· 38 citedOpen Access
Comparative effectiveness of heterologous booster schedules with AZD1222, BNT162b2, or mRNA-1273 vaccines against COVID-19 during omicron predominance in the Nordic countries
2022· 3 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Xavier Kurz(6), Dominique Rosillon(6), Vincent Bauchau(5), Gaël Dos Santos(5), Germano Ferreira(5), Vivek Shinde(5), Emmanuel Aris(5), Chantal Quinten(4), Jeanne‐Marie Devaster(4), Stuart C. Clarke(4), Tom Wilkinson(4), Corinne Willame(4), Shih-Lung Cheng(3), Neil Pearce(3), Keith Grimwood(3), Daniel Prieto‐Alhambra(3), Nathalie Largeron(3), Thomas Verstraeten(3), Kaatje Bollaerts(3), François Haguinet(3)